This invention is a method for osteoarthritis in vitro diagnosis and follow-up. It relies on a minimally invasive extraction of synovial fluid into the joint. The morphological analysis of a drop of synovial fluid provides a clear and simple diagnosis of osteoarthritis at the onset of the pathology. An additional spectroscopic analysis allows further assessment of the development stage and amount of inflammation, correlated to current osteoarthritis biomarkers (hyaluronic acid, chondroitin sulfate…). Currently, osteoarthritis diagnosis is late, when the disease is advanced and the first clinical symptoms appear. This test provides a simple and efficient solution to detect and assess early-stage osteoarthritis cases, and follow the disease progression in humans or animals.
PULSALYS is looking for :
> industrial partners interested in developing or co-developing a therapeutic drug targeting this protein,
> business profiles interested in entrepreneurship / startup.